首页 › 滤泡性淋巴瘤 › 俄亥俄州 › Cincinnati
Cincinnati OH 滤泡性淋巴瘤临床试验
9项针对 滤泡性淋巴瘤的研究正在 Cincinnati及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
招募中3 期
- Research Site, Cincinnati
- Research Site, Blue Ash · 距离 10 英里
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
招募中3 期
- St Elizabeth Healthcare, Edgewood · 距离 8 英里
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
招募中观察性研究
- University of Cincinnati, Cincinnati
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
招募中3 期
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 距离 15 英里
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
招募中1/2 期
- University of Cincinnati (UC) Physicians Company, LLC, Cincinnati
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- University of Cincinnati Medical Center, Cincinnati
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
招募中观察性研究
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
招募中1 期
- University of Cincinnati, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Cincinnati
其他城市的 滤泡性淋巴瘤试验
- New York City, NY24 项研究
- Milwaukee, WI19 项研究
- Houston, TX18 项研究
- Nashville, TN18 项研究
- Boston, MA17 项研究
- Baldwin Park, CA16 项研究
- Seattle, WA16 项研究
- Durham, NC15 项研究
- Columbus, OH14 项研究
- Salt Lake City, UT12 项研究
- Philadelphia, PA12 项研究
- San Antonio, TX12 项研究
Cincinnati的其他研究
- 非小细胞肺癌35 项研究
- 癌症（所有类型）28 项研究
- 乳腺癌25 项研究
- 心力衰竭24 项研究
- 结直肠癌21 项研究
- 转移性癌症20 项研究
- 急性髓系白血病20 项研究
- 肺癌19 项研究
- 卵巢癌19 项研究
- 肥胖症19 项研究
- 前列腺癌18 项研究
- 多发性骨髓瘤17 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。